<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>Product Liability Attorney Blog</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/" />
    <link rel="self" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/atom.xml" />
   <id>tag:,2009:/138</id>
    <link rel="service.post" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138" title="Product Liability Attorney Blog" />
    <updated>2009-06-22T19:26:56Z</updated>
    <subtitle>Published by Carey &amp; Danis, L.L.C.</subtitle>
    <generator uri="http://www.sixapart.com/movabletype/">Movable Type 3.33</generator>
 
<entry>
    <title>Chinese Drywall Stench Detected by Construction Workers</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/06/chinese_drywall_stench_detecte.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=46939" title="Chinese Drywall Stench Detected by Construction Workers" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.46939</id>
    
    <published>2009-06-05T17:12:36Z</published>
    <updated>2009-06-22T19:26:56Z</updated>
    
    <summary>Construction workers hanging Chinese drywall complained of the off-putting stench to home developers, according to a Broward-Palm Beach New Times online report. According to journalist Eric Barton, some construction workers refused to work with the Chinese drywall, afraid that the...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Chinese Drywall" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Construction workers hanging<a href="http://www.careydanis.com/lawyer-attorney-1264433.html"> Chinese drywall </a>complained of the off-putting stench to home developers, according to a <em><a href="http://blogs.browardpalmbeach.com/juice/2009/06/chinese_drywall_lennar_sulfur_dioxide.php">Broward-Palm Beach New Times </em>online report</a>.</p>

<p>According to journalist Eric Barton, some construction workers refused to work with the Chinese drywall, afraid that the smell meant the material was rotten. Barton also writes that some contractors told workers to paint the drywall quickly in order to mask the smell.</p>

<p>Homeowners have been driven out of their houses by the rotten-egg smell of sulfur dioxide. The sulfur dioxide can be toxic and has been blamed for corroding wires and pipes leading to the ruin of appliances and household systems such as air conditioners. <a href="http://www.cpsc.gov/info/drywall/index.html">The Consumer Product Safety Commission</a> indicates that the problems seem to be concentrated in homes built in 2006 and 2007.</p>]]>
        <![CDATA[<p>If you own a home with defective Chinese drywall, contact<a href="http://www.careydanis.com"> Carey & Danis</a>. We can help. For more information, fill out our <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">online contact form </a>or call Carey & Danis toll-free at 800-721-2519.</p>]]>
    </content>
</entry>
<entry>
    <title>Seniors Taking Cipro Risk Tendon Tears</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/06/seniors_taking_cipro_risk_tend.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=46748" title="Seniors Taking Cipro Risk Tendon Tears" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.46748</id>
    
    <published>2009-06-01T19:40:02Z</published>
    <updated>2009-06-03T17:20:11Z</updated>
    
    <summary>Patients over the age of 65 who are taking Cipro are at risk for tendon tears, the U.S. Food and Drug Administration has warned. Ciproflaxin is a powerful antibiotic that is used to treat bacterial infections of the bladder, kidney,...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Levaquin" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Patients over the age of 65 who are taking <a href="http://www.careydanis.com/lawyer-attorney-1364830.html">Cipro</a> are at risk for tendon tears, the <a href="http://www.careydanis.com/files/cipro_oral_ppi.pdf">U.S. Food and Drug Administration </a>has warned.</p>

<p>Ciproflaxin is a powerful antibiotic that is used to treat bacterial infections of the bladder, kidney, prostate gland, cervix, stomach, intestine, lung, sinus, bone, and skin and as a preventive measure after exposure to anthrax. Made by Bayer AG, it is sold under a variety of names including Cipro, Ciproxin, Ciprobay, and Cipro XR.</p>

<p>On July 8, 2008, the FDA added a black box label warning to Cipro in order alert patients of possible tendon ruptures and tendinitis. </p>

<p>According to the warning, “the risk of tendon effects is higher if you are over 65 years of age, and especially if you are taking corticosteroids.”</p>

<p>Anyone who has been given ciprofloxacin and experiences pain, swelling or inflammation in the area of a tendon should stop taking the drug and contact his or her physician. Patients who experience a snapping or popping sensation in the area of a tendon, note bruising right after an injury in the area of a tendon or are unable to move or bear weight after taking the drug should also contact a doctor immediately.</p>]]>
        <![CDATA[<p>If you or a loved one has suffered a serious complication after taking ciprofloxacin, <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact the attorneys of Carey & Danis</a>. We can help. <a href="http://www.careydanis.com">Carey & Danis </a>is a national law firm that represents individuals injured by America's largest corporations.</p>]]>
    </content>
</entry>
<entry>
    <title>Tendon Troubles Lead to Levaquin Lawsuits</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/06/tendon_ruptures_lead_to_levaquin_lawsuits.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=46736" title="Tendon Troubles Lead to Levaquin Lawsuits" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.46736</id>
    
    <published>2009-06-01T17:13:57Z</published>
    <updated>2009-06-01T17:25:14Z</updated>
    
    <summary>Three patients who were prescribed Levaquin recently filed suit against the maker of the antibiotic in a New Jersey state court, The Wall Street Journal reports. The lawsuits claim that Johnson &amp; Johnson and its Ortho McNeil unit touted Levaquin...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Levaquin" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Three patients who were prescribed <a href="http://www.careydanis.com/lawyer-attorney-1351304.html">Levaquin</a> recently filed suit against the maker of the antibiotic in a New Jersey state court, <em><a href="http://online.wsj.com/article/SB124301204907647689.html">The Wall Street Journal </a></em>reports.</p>

<p>The lawsuits claim that Johnson & Johnson and its Ortho McNeil unit touted Levaquin as a safe treatment for bacterial infections even though the companies allegedly knew that it could cause severe tendon ruptures and tendonitis.</p>

<p>On July 8, 2008, the <a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm084316.htm">FDA issued an alert </a>requiring Ortho to add a black-box warning to Levaquin’s label. The warning advises patients that Levaquin increases their risk of tendinitis—inflammation or irritation of a tendon, one of the thick fibrous cords that connect muscle to bone. Some patients who have taken Levaquin have reported the rupture of tendons in the shoulder, hand and heel.</p>

<p>The risk of tendinitis and tendon rupture is increased in patients older than 60; in kidney, heart, and lung transplant recipients; and in patients given Levaquin in conjunction with steroid therapy.</p>

<p>If you or a loved one has suffered a serious complication after taking Levaquin, <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact the attorneys of Carey & Danis</a>. We can help. <a href="http://careydanis.com">Carey & Danis </a>is a national law firm that represents individuals injured by America’s largest corporations.</p>]]>
        
    </content>
</entry>
<entry>
    <title>Heartburn Drug Reglan Linked to Spasms, Tics</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/04/heartburn_drug_reglan_linked_t.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=42804" title="Heartburn Drug Reglan Linked to Spasms, Tics" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.42804</id>
    
    <published>2009-04-14T16:25:09Z</published>
    <updated>2009-05-06T21:20:02Z</updated>
    
    <summary>On April 8, 2009, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it had begun a withdrawal of Raptiva from the U.S. market because of its link to patients developing progressive multifocal leukoencephalopathy (PML), a neurologic disease...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>On April 8, 2009, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it had begun a withdrawal of Raptiva from the U.S. market because of its link to patients developing progressive multifocal leukoencephalopathy (PML), a neurologic disease caused by a virus that affects the central nervous system. PML is associated with long-term Raptiva use and generally occurs in people whose immune systems have been severely weakened. It often leads to an irreversible decline in neurologic function and death. There is no known effective treatment for PML.</p>]]>
        
    </content>
</entry>
<entry>
    <title>Seroquel’s Maker Paid FDA Committee Member</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/04/seroquels_maker_paid_fda_committee_member.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=42223" title="Seroquel’s Maker Paid FDA Committee Member" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.42223</id>
    
    <published>2009-04-09T23:55:32Z</published>
    <updated>2009-04-09T23:59:07Z</updated>
    
    <summary>A Florida child psychiatrist who was paid by AstraZeneca to talk to other physicians about the antipsychotic drug Seroquel is also the chair of an influential FDA committee, the Philadelphia Inquirer reports. Dr. Jorge Armenteros was not only AstraZeneca’s paid...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>A Florida child psychiatrist who was paid by AstraZeneca to talk to other physicians about the <a href="http://www.careydanis.com/lawyer-attorney-1264433.html">antipsychotic drug Seroquel </a>is also the chair of an influential FDA committee, the <a href="http://www.philly.com/inquirer/business/20090404_Conflicts_for_FDA_committee_set_to_weigh_risks_of_Seroquel.html"><em>Philadelphia Inquirer </em></a>reports.</p>

<p>Dr. Jorge Armenteros was not only AstraZeneca’s paid speaker, he is also the chair and voting member of the FDA advisory committee that will decide whether Seroquel XR, an extended-release version of Seroquel, should be approved to treat depression and anxiety. However, the day before the Philadephia Inquirer story appeared in print, it was announced that Armenteros would not be voting on the request.</p>

<p>Seroquel is currently approved only for the treatment of schizophrenia and bipolar disorder. Last year, it generated $4.45 billion in sales. There are approximately 20 million people in the United States who suffer from anxiety and depression. If the FDA approves the expansion, sales of Seroquel could soar. </p>

<p>So too could the number of people suffering dangerous Seroquel side effects such as diabetes, high blood pressure and sudden cardiac death. </p>

<p>Lawsuits have been filed against AstraZeneca alleging that the drugmaker hid <a href="http://www.fda.gov/CDER/drug/InfoSheets/patient/quetiapinePIS.htm">the dangers associated with Seroquel</a> from patients and many were seriously injured as a result.</p>]]>
        <![CDATA[<p>If you or a loved one has suffered a serious complication after taking Seroquel, <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact the Seroquel attorneys</a> of Carey & Danis. We can help. Carey & Danis is a national law firm that represents individuals injured by America's largest corporations.</p>]]>
    </content>
</entry>
<entry>
    <title>Yamaha Rhino ATV Sales Suspended</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/04/yamaha_rhino_atv_sales_suspend.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=41947" title="Yamaha Rhino ATV Sales Suspended" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.41947</id>
    
    <published>2009-04-09T01:03:11Z</published>
    <updated>2009-04-09T01:13:29Z</updated>
    
    <summary>Sales of Yamaha Rhino ATVs have been suspended because scores of deaths and injuries have occurred after the all-terrain vehicles rolled over on their drivers and passengers. Sales were halted on March 31 when the federal government announced a free...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Sales of <a href="http://www.careydanis.com/lawyer-attorney-1264483.html">Yamaha Rhino ATVs </a>have been suspended because scores of deaths and injuries have occurred after the all-terrain vehicles rolled over on their drivers and passengers. </p>

<p>Sales were halted on March 31 when the federal government announced a free repair program for more than 120,000 Yamaha Rhino models 450, 660 and 700.</p>

<p>According to the announcement from the <a href="http://www.cpsc.gov/cpscpub/prerel/prhtml09/09172.html">U.S. Consumer Product Safety Commission</a>, the Rhino has been linked to the deaths of at least 46 ATV drivers and passengers. </p>

<p>The repair program includes the installation of a spacer on the rear wheels, removal of the rear anti-sway bar, the installation of half-doors and passenger holds.</p>]]>
        <![CDATA[<p>If you or a loved one has been injured by an ATV in a rollover accident, <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact Carey & Danis</a>. We can help. Carey & Danis is a national law firm that represents individuals injured by America's largest corporations.</p>

<p>Based in St. Louis, Missouri and Godfrey, Illinois, our lawyers have recovered over $695 million for our clients, including individual settlements of over $10 million and class-wide settlements of over $90 million. It is our clients who are our most important asset.</p>]]>
    </content>
</entry>
<entry>
    <title>FDA Reviews Risks of Seroquel</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/04/fda_reviews_risks_of_seroquel.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=42201" title="FDA Reviews Risks of Seroquel" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.42201</id>
    
    <published>2009-04-06T20:11:39Z</published>
    <updated>2009-04-07T14:42:21Z</updated>
    
    <summary>This week federal health officials will weigh the risks of approving the antipsychotic drug Seroquel for the treatment of depression – even though sudden heart death is one of Seroquel’s side effects. AstraZeneca, the London-based company that makes the drug,...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>This week federal health officials will weigh the risks of approving the <a href="http://www.careydanis.com/lawyer-attorney-1264433.html">antipsychotic drug Seroquel </a>for the treatment of depression – even though sudden heart death is one of Seroquel’s side effects.</p>

<p>AstraZeneca, the London-based company that makes the drug, wants the <a href="http://www.fda.gov/CDER/drug/InfoSheets/patient/quetiapinePIS.htm">U.S. Food and Drug Administration </a>to approve Seroquel for depression and anxiety disorder patients. According to the <a href="http://www.startribune.com/lifestyle/health/42416702.html?elr=KArksLckD8EQDUoaEyqyP4O:DW3ckUiD3aPc:_Yyc:aUUsZ">Associated Press</a>, millions of patients already use Seroquel for the treatment of schizophrenia and bipolar disorder. If the FDA expands the list of approved conditions, more than 20 million people in the United States could potentially receive Seroquel.</p>

<p>But there are serious safety concerns.</p>

<p>A recent <em><a href="http://content.nejm.org/cgi/content/extract/360/3/294">New England Journal of Medicine </a></em>article indicated that drugs like Seroquel can increase the risk of sudden cardiac death. Seroquel side effects also include high blood pressure and diabetes. </p>

<p>AstraZeneca is also facing a number of lawsuits that claim the <a href="http://www.careydanis.com/lawyer-attorney-1264601.html">drugmaker kept the dangers associated with Seroquel hidden</a>. </p>]]>
        <![CDATA[<p>If you or a loved one has suffered a serious complication after taking Seroquel, <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact the Seroquel lawyers </a>of Carey & Danis. We can help. Carey & Danis is a national law firm that represents individuals injured by America's largest corporations.</p>]]>
    </content>
</entry>
<entry>
    <title>Seroquel Side Effects</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/04/seroquel_side_effects.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=42176" title="Seroquel Side Effects" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.42176</id>
    
    <published>2009-04-06T17:24:14Z</published>
    <updated>2009-04-06T17:44:52Z</updated>
    
    <summary>The antipsychotic drug Seroquel, made by AstraZeneca, has been linked to an increased risk for developing high blood pressure, diabetes and sudden heart death. The U.S. Food and Drug Administration approved Seroquel for the treatment of schizophrenia, a condition that...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>The <a href="http://www.careydanis.com/lawyer-attorney-1264433.html">antipsychotic drug Seroquel</a>, made by AstraZeneca, has been linked to an increased risk for developing high blood pressure, diabetes and sudden heart death.</p>

<p>The <a href="http://www.fda.gov/CDER/drug/InfoSheets/patient/quetiapinePIS.htm">U.S. Food and Drug Administration </a>approved Seroquel for the treatment of schizophrenia, a condition that may include hearing voices, seeing or sensing things that are not present, mistaken beliefs or unusual suspicions.  Seroquel is also approved as a treatment for bipolar disorder, a mental illness that causes extreme mood swings. Seroquel has also been prescribed to treat dementia even though the FDA has not been approved it for that purpose.</p>

<p>Seroquel has been associated with some severe and deadly side effects. The Seroquel side effects lawyers at Carey & Danis believe that AstraZeneca kept the dangers associated with Seroquel secret. As a result, a number of patients prescribed Seroquel suffered serious injuries.</p>

<p>The Food and Drug Administration now warns that there are several risks and side effects associated with Seroquel therapy including:</p>

<blockquote>An increased chance of death in elderly person 

<p>Neuroleptic malignant syndrome (NMS), a life-threatening nervous system problem that can cause high fever, muscle stiffness, sweating, a fast or irregular heartbeat, a change in blood pressure and confusion</p>

<p>An uncontrollable muscle movement condition known as tardive dyskinesia</p>

<p>High blood sugar and diabetes</blockquote></p>]]>
        <![CDATA[<p>If you or a loved one has suffered a serious complication after taking Seroquel, <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact the Seroquel side effect attorneys</a> of Carey & Danis. We can help. <a href="http://www.careydanis.com/index.html">Carey & Danis</a> is a national law firm that <a href="http://www.careydanis.com/lawyer-attorney-1264601.html">represents individuals </a>injured by America's largest corporations.</p>]]>
    </content>
</entry>
<entry>
    <title>Carey &amp; Danis LLC Announces Auction Rate Securities Class Action Lawsuit Filed Against H&amp;R Block </title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/04/carey_danis_llc_announces_auction_rate_securities_class_action_lawsuit_filed_against_hr_block_.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=42015" title="Carey &amp; Danis LLC Announces Auction Rate Securities Class Action Lawsuit Filed Against H&amp;R Block " />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.42015</id>
    
    <published>2009-04-03T20:05:31Z</published>
    <updated>2009-04-04T15:44:37Z</updated>
    
    <summary>NEWS RELEASE March 27, 2009 Carey &amp; Danis LLC Announces Auction Rate Securities Class Action Lawsuit Filed Against H&amp;R Block St. Louis, MO – The law firm of Carey &amp; Danis LLC (www.careydanis.com) has filed a class action lawsuit on...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Auction Rate Securities" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>NEWS RELEASE<br />
 <br />
March 27, 2009<br />
 <br />
<strong>Carey & Danis LLC Announces Auction Rate Securities Class Action Lawsuit Filed Against H&R Block </strong> </p>

<p>St. Louis, MO – The law firm of Carey & Danis LLC (www.careydanis.com) has filed a class action lawsuit on behalf of persons who purchased auction rate securities from H&R Block, Inc. (NYSE: HRB), and H&R Block Financial Advisors, Inc., between Aug. 26, 2003 and Feb. 13, 2008 and who continued to hold the securities as of Feb. 13, 2008.<br />
 <br />
The class action lawsuit, La Grave v. H&R Block, Inc., et al., 08-cv-667, is pending in the U.S. District Court for the Southern District of Illinois.  The suit alleges that H&R Block, Inc. and its subsidiary H&R Block Financial Advisors, Inc., violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by deceiving investors about the investment characteristics of auction rate securities and the auction market in which the securities are traded.<br />
 <br />
Auction rate securities are municipal or corporate debt securities or preferred stocks that pay interest at rates set through periodic auctions.  The instruments typically have long-term maturity dates or no maturity date.</p>

<p>The suit filed on Sept. 24, 2008 claims that, pursuant to uniform sales materials and top-down management directives, H&R Block offered and sold auction rate securities to the public as highly liquid cash-management instruments and as suitable alternatives to money market mutual funds.  On Feb. 13, 2008, all of the major broker-dealers, including H&R Block, withdrew their support for the auctions.  The suit claims that, as a result, investors have been unable to liquidate their auction rate securities. <br />
 <br />
The lawsuit alleges that H&R Block failed to disclose the following material facts about the auction rate securities it sold to the class:<br />
 <br />
<blockquote>• The auction rate securities were not cash alternatives like money market funds but were instead complex long-term financial instruments with 30-year maturity dates.<br />
• The auction rate securities were only liquid at the time of the sale because H&R Block and other broker-dealers were artificially supporting and manipulating the market to maintain the appearance of liquidity and stability.<br />
• H&R Block and other broker-dealers routinely intervened in the auctions for their own benefit to set rates and to prevent all-hold auctions and failed auctions.<br />
• H&R Block continued to market auction rate securities as liquid investments even after H&R Block and other broker-dealers determined that they would likely be withdrawing support for the periodic auctions and that a freeze of the auction rate securities market would result.</blockquote> <br />
Investors who purchased or acquired auction rate securities from H&R Block between Aug. 26, 2003, and Feb. 13, 2008, and who continued to hold the securities as of Feb. 13, 2008, may request appointment as lead plaintiff by the Court on or before May 26, 2009.  A lead plaintiff is a representative party acting on behalf of other class members.  To be appointed, the Court must conclude that the investor’s claims are typical of other class members’ and that the investor will adequately represent the class.  The investor’s ability to share in any recovery is not affected by the decision to serve as lead plaintiff.  The investor may retain Carey & Danis LLC, or other attorneys, to serve as counsel.<br />
 <br />
Auction rate securities investors who wish to discuss their rights against H&R Block or any other broker-dealer may contact Carey & Danis LLC toll-free at 800-721-2519.  A copy of the lawsuit is available from the Court.<br />
 <br />
Carey & Danis LLC is a national law firm based in St. Louis that aids victims of corporate abuse, greed and neglect. <br />
 <br />
###<br />
CONTACT:  <br />
JOSEPH P. DANIS<br />
jdanis@careydanis.com<br />
MICHAEL J. FLANNERY<br />
mflannery@careydanis.com<br />
COREY D. SULLIVAN<br />
csullivan@careydanis.com<br />
Phone:  1-800-721-2519<br />
www.careydanis.com</p>]]>
        
    </content>
</entry>
<entry>
    <title>Yamaha Rhino ATV Rollover and Recall</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/04/yamaha_rhino_atv_rollover_and_recall.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=41937" title="Yamaha Rhino ATV Rollover and Recall" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.41937</id>
    
    <published>2009-04-02T23:28:35Z</published>
    <updated>2009-04-03T15:26:59Z</updated>
    
    <summary>Yamaha Rhino owners have been advised to stop operating certain models of the all-terrain vehicles because of rollover concerns. On March 31, the U.S. Consumer Product Safety Commission, in cooperation with Yamaha Motor Corp., announced a free repair program to...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Yamaha Rhino owners have been advised to stop operating certain models of the all-terrain vehicles because of <a href="http://www.careydanis.com/lawyer-attorney-1264483.html">rollover concerns</a>.</p>

<p>On March 31, the <a href="http://www.cpsc.gov/cpscpub/prerel/prhtml09/09172.html">U.S. Consumer Product Safety Commission</a>, in cooperation with Yamaha Motor Corp., announced a free repair program to address safety issues with the Rhino 450, 660 and 700 models of off-highway recreational vehicles.</p>

<p>There have been 46 deaths of ATV drivers and ATV passengers linked to the Rhino 450 and 660. More than two-thirds of the fatalities involved rollovers. Unbelted Rhino occupants were also involved in many of the deaths. Many of the incidents involving ATV deaths or serious injuries occurred while operating the ATVs at slow speeds on relatively level terrain.</p>

<p>The repair program includes the installation of a spacer on the rear wheels, removal of the rear anti-sway bar, the installation of half-doors and the installation of passenger holds.</p>]]>
        <![CDATA[<p>If you or a loved one has been injured by an ATV in a rollover accident, <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact Carey & Danis</a>. We can help. Carey & Danis is a national law firm that represents individuals injured by America's largest corporations.</p>

<p>Based in St. Louis, Missouri and Godfrey, Illinois, our lawyers have recovered over $695 million for our clients, including individual settlements of over $10 million and class-wide settlements of over $90 million. It is our clients who are our most important asset.</p>]]>
    </content>
</entry>
<entry>
    <title>Madoff’s Millions</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/03/madoffs_millions.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=40470" title="Madoff’s Millions" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.40470</id>
    
    <published>2009-03-17T15:20:17Z</published>
    <updated>2009-04-02T20:19:01Z</updated>
    
    <summary>A villa in France, a penthouse apartment in New York, a home in Palm Beach – these are just a few of the items the federal government is seeking in a forfeiture proceeding against Bernard Madoff, the Wall Street Journal...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Securities Fraud" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>A villa in France, a penthouse apartment in New York, a home in Palm Beach – these are just a few of the items the federal government is seeking in a forfeiture proceeding against Bernard Madoff, the <a href="http://www.wsj.com">Wall Street Journal </a>reports.</p>

<p>But don’t expect Madoff to give up the assets – which also include boats, cars, $17 million in cash and $45 million in bonds – without a fight. Many of the assets are titled in the name of Madoff’s wife, Ruth, and lawyers for the Madoffs are expected to argue that she is independently wealthy.</p>

<p>As Bernard Madoff, the mastermind behind a <a href="http://www.careydanis.com/lawyer-attorney-1264493.html">multibillion Ponzi scheme</a>, fights to preserve his family fortune, many of his investors are still trying to come to terms with the fact that they’ve lost everything as a result of Madoff’s fraud.</p>]]>
        <![CDATA[<p>Carey & Danis pursues numerous securities fraud cases on behalf of defrauded individual and institutional investors. Investors who wish to discuss their rights against Madoff Investment Securities or against companies that invested money with Madoff may contact Carey & Danis toll-free at 800-721-2519 or fill out our online <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact form.</a><br />
</p>]]>
    </content>
</entry>
<entry>
    <title>Heparin Deaths Trigger Tougher Testing</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/02/heparin_deaths_trigger_tougher_testing.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=38786" title="Heparin Deaths Trigger Tougher Testing" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.38786</id>
    
    <published>2009-02-25T16:20:34Z</published>
    <updated>2009-02-26T16:58:33Z</updated>
    
    <summary>Hundreds of deaths last year were linked to tainted batches of heparin. Now, new standards for testing the blood thinner are scheduled to go into effect, Bloomberg News reports. The nonprofit health group, U.S. Pharmacopeial Convention, which is responsible for...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Heparin" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Hundreds of deaths last year were linked to tainted batches of <a href="http://www.careydanis.com/lawyer-attorney-1306818.html">heparin</a>. Now, new standards for testing the blood thinner are scheduled to go into effect, <a href="http://www.dailyherald.com/story/?id=269574">Bloomberg News </a>reports.</p>

<p>The nonprofit health group, <a href="http://www.usp.org/">U.S. Pharmacopeial Convention</a>, which is responsible for setting standards for the quality, purity, strength and consistency of medicines, unveiled a plan that would include three identification tests and screening for organic impurities beginning Aug. 1.</p>

<p><a href="http://vocuspr.vocus.com/vocuspr30/Newsroom/ViewAttachment.aspx?SiteName=USPharm&Entity=PRAsset&AttachmentType=F&EntityID=107217&AttachmentID=12d5d124-09b8-4a6b-a99a-cbd648c15bf8">In a news release</a>, Roger L. Williams MD, UPC’s chief executive officer, stated:</p>

<blockquote>“The tragedies involving heparin and glycerin demonstrate the shortcomings of 20th century safety nets in a 21st century global manufacturing supply chain. The reality is that with the decentralized, complex and global nature of today’s manufacturing environment, it is too easy for an unscrupulous supplier—driven by economic or even more frightening motives—to add an ingredient to a drug product that shouldn’t be there, putting us all at risk. </blockquote>]]>
        <![CDATA[<p>Heparin, derived from pig intestines, is typically injected into patients to reduce the risk of blood clots in catheters or during kidney dialysis and cardiac surgery.</p>

<p>Baxter International, one of the largest producers of heparin in the U.S., announced the voluntary recall of nine lots of heparin on Jan. 17, 2008, after reports of allergic-type reactions in patients given the drug. A month later, the FDA released a statement indicating that some patients who received heparin injections suffered symptoms, sometimes fatal, ranging from nausea and diarrhea to shortness of breath, dangerously low blood pressure and allergic or hypersensitivity reaction. </p>

<p>If you have a loved one who has been injured or died after receiving heparin, contact Carey & Danis. We can help. Carey & Danis is a <a href="http://www.careydanis.com/lawyer-attorney-1264599.html">national law firm </a>that represents <a href="http://www.careydanis.com/lawyer-attorney-1264601.html">personal injury victims and their families</a>.</p>

<p>For more information, fill out our <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">online contact form </a>or call Carey & Danis toll-free at 800-721-2519.</p>]]>
    </content>
</entry>
<entry>
    <title>Madoff Must Have Had Help</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/02/madoff_must_have_had_help.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=38726" title="Madoff Must Have Had Help" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.38726</id>
    
    <published>2009-02-24T20:26:59Z</published>
    <updated>2009-02-26T16:57:54Z</updated>
    
    <summary>Last week’s finding that Bernard Madoff didn’t trade any securities for more than ten years lends support to the claims that he could not have carried out the largest Ponzi scheme in history all alone, Bloomberg News reports. Late last...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Securities Fraud" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Last week’s finding that Bernard Madoff didn’t trade any securities for more than ten years lends support to the claims that he could not have carried out the largest Ponzi scheme in history all alone, <a href="http://www.bloomberg.com/apps/news?pid=20601103&sid=aggq1e88xMPU&refer=us#">Bloomberg News </a>reports.</p>

<p>Late last year, Madoff told federal investigators that he was solely responsible for the $50 billion <a href="http://www.careydanis.com/lawyer-attorney-1264493.html">securities fraud scam</a>. But that seems unlikely. According to the bankruptcy trustee liquidating Madoff’s securities firm, it now appears there were no trades for at least a decade. At the same time, the firm sent client statements showing trading activity and market prices.</p>

<p>In an interview with Bloomberg, Columbia University Law School professor John Coffee noted:</p>

<blockquote>“Someone had to creatively imagine what to tell all those clients.”</blockquote>

<p>In addition to employees of the securities firm, Coffee indicated that feeder fund managers may also find them exposed to criminal charges.</p>

<blockquote>“If prosecutors can show a kickback or any kind of undisclosed payments to feeder funds, then it will be much simpler for private investors to sue those feeder funds and it can support indictment under mail and wire fraud statutes.”</blockquote>]]>
        <![CDATA[<p>Carey & Danis pursues numerous securities fraud cases on behalf of defrauded individual and institutional investors. Investors who wish to discuss their rights against Madoff Investment Securities or against companies that invested money with Madoff may contact Carey & Danis toll-free at 800-721-2519 or fill out our <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">online contact form</a>.</p>]]>
    </content>
</entry>
<entry>
    <title>Sale of Madoff Brokerage Won&apos;t Reimburse Investors</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/01/sale_of_madoff_brokerage_wont_1.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=35413" title="Sale of Madoff Brokerage Won't Reimburse Investors" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.35413</id>
    
    <published>2009-01-20T15:42:14Z</published>
    <updated>2009-01-20T15:52:21Z</updated>
    
    <summary>Victims who had hoped to recoup $50 billion worth of losses from the sale of Bernard Madoff’s brokerage will likely be disappointed by a report that estimates the brokerage will fetch no more than $10 million. According to Bloomberg News,...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Securities Fraud" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Victims who had hoped to recoup <a href="http://www.careydanis.com/lawyer-attorney-1264493.html">$50 billion worth of losses </a>from the sale of Bernard Madoff’s brokerage will likely be disappointed by a report that estimates the brokerage will fetch no more than $10 million.</p>

<p>According to <a href="http://www.bloomberg.com/apps/news?pid=20601087&sid=aDFn38HrL4Ug&refer=home#">Bloomberg News</a>, a profit report prepared by investment bank Lazard Ltd. concluded that the brokerage earned only $1.12 million last year.  In addition, the brand is now tarnished because of the alleged Ponzi scheme that cost investors billions of dollars.</p>

<p>Recently, <a href="http://s.wsj.net/public/resources/documents/st_madoff_victims_20081215.html"><em>The Wall Street Journal </em></a>compiled an extensive list of Madoff’s most over-exposed investors. In addition to those mentioned in our previous posting, some of the charities, hedge funds and banks that could sustain staggering losses include:</p>

<blockquote>The British bank Royal Bank of Scotland Group PLC which had a potential exposure of almost $500 million as a result of trading through Madoff and collateralized lending to funds of hedge funds.

<p>BNB Paribas, a French bank, could lose up approximately $430 million through its trading business and collateralized lending to funds of hedge funds.</p>

<p>Spanish bank BBVA could lose almost $370 million if Madoff funds were not found to exist.</p>

<p>Man Group PLC, a U.K. hedge fund, estimates it could lose $360 million as a result of investing directly in Madoff funds and indirectly sub-advised by Madoff Securities and for which Madoff acts as a broker-dealer.</blockquote></p>]]>
        <![CDATA[<p>Brokers and hedge funds must conduct a due diligence investigation before turning a client’s money over to another investment firm. In the Madoff debacle, middlemen that acted as a go-between are now facing lawsuits from angry investors claiming a lack of due diligence.</p>

<p>Carey & Danis pursues numerous securities fraud cases on behalf of defrauded individual and institutional investors. Investors who wish to discuss their rights against Madoff Investment Securities or against companies that invested money with Madoff may contact Carey & Danis toll-free at 800-721-2519 or fill out our online <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">contact form.</a></p>]]>
    </content>
</entry>
<entry>
    <title>Auction-Rate Securities Investors Continue to Struggle</title>
    <link rel="alternate" type="text/html" href="http://www.productliabilityattorneyblog.com/2009/01/auctionrate_securities_investo_1.html" />
    <link rel="service.edit" type="application/atom+xml" href="http://www.productliabilityattorneyblog.com/cgi-bin/mt-atom.cgi/weblog/blog_id=138/entry_id=34914" title="Auction-Rate Securities Investors Continue to Struggle" />
    <id>tag:www.productliabilityattorneyblog.com,2009://138.34914</id>
    
    <published>2009-01-16T18:06:21Z</published>
    <updated>2009-01-16T18:15:14Z</updated>
    
    <summary>Glenn and Norma Linke, a retired couple living in St. Louis, thought their money had been invested safely. But last year, when they asked their broker at Stifel Nicolaus to sell their “weekly CDs” in order to pay the costs...</summary>
    <author>
        <name>Carey &amp; Danis, L.L.C.</name>
        
    </author>
            <category term="Auction Rate Securities" />
    
    <content type="html" xml:lang="en" xml:base="http://www.productliabilityattorneyblog.com/">
        <![CDATA[<p>Glenn and Norma Linke, a retired couple living in St. Louis, thought their money had been invested safely. But last year, when they asked their broker at Stifel Nicolaus to sell their “weekly CDs” in order to pay the costs of building a first-floor bedroom, they were in for an unpleasant surprise. Their money had not been used to purchase certificates of deposits. Instead, it had been invested in <a href="http://www.careydanis.com/lawyer-attorney-1295796.html">auction rate securities </a>that could not be sold.</p>

<p>The <em>St. Louis Post-Dispatch </em>reported on the plight of the Linkes last Sunday. Nearly a year after the auction-rate securities market froze the Linkes still cannot access approximately $75,000 of their money.</p>

<p>The Missouri Secretary of State negotiated buy-back agreements with Wachovia Securities in St. Louis and Commerce Bank. But Stifel, the third-largest brokerage based in St. Louis, wasn’t part of the deal. </p>

<p>According to the article, <a href="http://www.stltoday.com/stltoday/business/stories.nsf/yourmoney/story/E3C30135AB9F52388625753A000DFECC?OpenDocument">“St. Louis couples angry at Stifel Nicolaus over auction rate securities,”</a> Stifel claims it has done nothing wrong. Other regional brokerages such as Raymond James Financial are taking a similar position.</p>

<p>As a result, thousands of investors like the Linkes are still unable to retrieve their hard-earned money.</p>]]>
        <![CDATA[<p>Auction-rate securities are municipal or corporate debt securities or preferred stocks that pay interest at rates set through periodic auctions. The instruments typically have long-term maturity dates or no maturity date.</p>

<p>In mid-February 2008, the auctions for the investment instruments failed. That meant investors were unable to sell their securities. To this day, auction-rate securities investors find themselves owning frozen assets.</p>

<p>Auction-rate securities investors who wish to discuss their rights against any broker-dealer may contact Carey & Danis toll-free at 800-721-2519 or fill out our <a href="http://www.careydanis.com/lawyer-attorney-1263598.html">online contact form </a><br />
</p>]]>
    </content>
</entry>

</feed> 

